Clinical presentation and early care relationships in 'poor-me' and 'bad-me' paranoiaMORRIS, Emma; MILNER, Philip; TROWER, Peter et al.British journal of clinical psychology. 2011, Vol 50, pp 211-216, issn 0144-6657, 6 p., 2Article

The Dorsomedial Suprachiasmatic Nucleus Times Circadian Expression of Kiss1 and the Luteinizing Hormone SurgeSMARR, Benjamin L; MORRIS, Emma; DE LA IGLESIA, Horacio O et al.Endocrinology (Philadelphia). 2012, Vol 153, Num 6, pp 2839-2850, issn 0013-7227, 12 p.Article

Risk-stratified adoptive cellular therapy following allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukaemiaRICHARDSON, Simon E; KHAN, Iftekhar; BENJAMIN, Reuben et al.British journal of haematology. 2013, Vol 160, Num 5, pp 640-648, issn 0007-1048, 9 p.Article

CD3 limits the efficacy of TCR gene therapy in vivoAHMADI, Maryam; KING, Judith W; XUE, Shao-An et al.Blood. 2011, Vol 118, Num 13, pp 3528-3537, issn 0006-4971, 10 p.Article

Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cellsXUE, Shao-An; LIQUAN GAO; STAUSS, Hans et al.Blood. 2005, Vol 106, Num 9, pp 3062-3067, issn 0006-4971, 6 p.Article

Autobiographical memory and post-psychotic depression in first episode psychosisIQBAL, Zaffer; BIRCHWOOD, Max; HEMSLEY, David et al.British journal of clinical psychology. 2004, Vol 43, pp 97-104, issn 0144-6657, 8 p., 1Article

Phase I Study of High-Stringency CD8 Depletion of Donor Leukocyte Infusions After Allogeneic Hematopoietic Stem Cell TransplantationORTI, Guillermo; LOWDELL, Mark; CHAKRAVERTY, Ronjon et al.Transplantation. 2009, Vol 88, Num 11, pp 1312-1318, issn 0041-1337, 7 p.Article

Generation of tumor-specific T-cell therapiesMORRIS, Emma; HART, Dan; LIQUAN GAO et al.Blood reviews. 2006, Vol 20, Num 2, pp 61-69, issn 0268-960X, 9 p.Article

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-hodgkin lymphomaMORRIS, Emma; THOMSON, Kirsty; HATTON, Christopher et al.Blood. 2004, Vol 104, Num 13, pp 3865-3871, issn 0006-4971, 7 p.Article

Autologous stem cell transplantation for follicular lymphoma is of most benefit early in the disease course and can result in durable remissions, irrespective of prior rituximab exposureKOTHARI, Jaimal; PEGGS, Karl S; BIRD, Antonia et al.British journal of haematology. 2014, Vol 165, Num 3, pp 334-340, issn 0007-1048, 7 p.Article

Development of a Wilms' tumor antigen-specific T-cell receptor for clinical trials: engineered patient's T cells can eliminate autologous leukemia blasts in NOD/SCID miceXUE, Shao-An; LIQUAN GAO; THOMAS, Sharyn et al.Haematologica (Roma). 2010, Vol 95, Num 1, pp 126-134, issn 0390-6078, 9 p.Article

Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitutionCHAKRAVERTY, Ronjon; ORTI, Guillermo; CLARK, Andrew et al.Blood. 2010, Vol 116, Num 16, pp 3080-3088, issn 0006-4971, 9 p.Article

Intracellular serpins in haemopoietic and peripheral blood cellsMORRIS, Emma C; CARRELL, Robin W; COUGHLIN, Paul B et al.British journal of haematology. 2001, Vol 115, Num 4, pp 758-766, issn 0007-1048Article

Adenoviremia Has Limited Clinical Impact in the Majority of Patients Following Alemtuzumab-Based Allogeneic Stem Cell Transplantation in AdultsSIVE, Jonathan I; THOMSON, Kirsty J; MORRIS, Emma C et al.Clinical infectious diseases. 2012, Vol 55, Num 10, pp 1362-1370, issn 1058-4838, 9 p.Article

Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: relevance for early adoptive immunotherapy and infectious complicationsMORRIS, Emma C; REBELLO, Peppy; THOMSON, Kirsty J et al.Blood. 2003, Vol 102, Num 1, pp 404-406, issn 0006-4971, 3 p.Article

Human T cells expressing affinity-matured TCR display accelerated responses but fail to recognize low density of MHC-peptide antigenTHOMAS, Sharyn; XUE, Shao-An; BANGHAM, Charles R. M et al.Blood. 2011, Vol 118, Num 2, pp 319-329, issn 0006-4971, 11 p.Article

Predominant or complete recipient T-cell chimerism following alemtuzumab-based allogeneic transplantation is reversed by donor lymphocytes and not associated with graft failureMOHAMEDBHAI, Sajir G; EDWARDS, Noha; MORRIS, Emma C et al.British journal of haematology. 2012, Vol 156, Num 4, pp 516-522, issn 0007-1048, 7 p.Article

Specificity for the tumor-associated self-antigen WT1 drives the development of fully functional memory T cells in the absence of vaccinationPOSPORI, Constandina; XUE, Shao-An; MORRIS, Emma C et al.Blood. 2011, Vol 117, Num 25, pp 6813-6824, issn 0006-4971, 12 p.Article

Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responsesPEGGS, Karl S; THOMSON, Kirsty; HART, Daniel P et al.Blood. 2004, Vol 103, Num 4, pp 1548-1556, issn 0006-4971, 9 p.Article

Wilms' Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responsesUTTENTHAL, Benjamin; MARTINEZ-DAVILA, Irma; MORRIS, Emma C et al.British journal of haematology. 2014, Vol 164, Num 3, pp 366-375, issn 0007-1048, 10 p.Article

Prognostic factors and outcome for children after second central nervous system relapse of acute lymphoblastic leukaemiaMORRIS, Emma C; HARRISON, Georgina; BAILEY, Clifford C et al.British journal of haematology. 2003, Vol 120, Num 5, pp 787-789, issn 0007-1048, 3 p.Article

Donor Lymphocyte Infusions Modulate Relapse Risk in Mixed Chimeras and Induce Durable Salvage in Relapsed Patients After T-Cell―Depleted Allogeneic Transplantation for Hodgkin's LymphomaPEGGS, Karl S; KAYANI, Irfan; THOMSON, Kirsty J et al.Journal of clinical oncology. 2011, Vol 29, Num 8, pp 971-978, issn 0732-183X, 8 p.Article

Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioningTOWNSEND, William M; HOLROYD, Ailsa; HOWELL, David C. J et al.British journal of haematology. 2013, Vol 161, Num 4, pp 578-586, issn 0007-1048, 9 p.Article

Favorable Long-Term Survival After Reduced-Intensity Allogeneic Transplantation for Multiple-Relapse Aggressive Non-Hodgkin's LymphomaTHOMSON, Kirsty J; MORRIS, Emma C; PEGGS, Karl S et al.Journal of clinical oncology. 2009, Vol 27, Num 3, pp 426-432, issn 0732-183X, 7 p.Article

T-Cell-Depleted Reduced-Intensity Transplantation Followed by Donor Leukocyte Infusions to Promote Graft-Versus-Lymphoma Activity Results in Excellent Long-Term Survival in Patients With Multiply Relapsed Follicular LymphomaTHOMSON, Kirsty J; MORRIS, Emma C; CHAKRAVERTY, Ronjon et al.Journal of clinical oncology. 2010, Vol 28, Num 23, pp 3695-3700, issn 0732-183X, 6 p.Article